BELEX15 Index
BEL152024-04-24 2:01:01 PM | Chg. +7.87 | Open | High | Low | Previous Close |
---|---|---|---|---|---|
1,006.10RSD | +0.79% | 1,001.51 | 1,006.10 | 1,001.51 | 998.23 |
GlobeNewswire
4:09 PM
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antib...
GlobeNewswire
4:08 PM
Blue Island Homes Chosen as Exclusive Listing Brokers for Ocean Watch at Harbor Pointe: A Premier Ga...
GlobeNewswire
4:06 PM
Juniata Valley Financial Corp. Announces Results for the Quarter Ended March 31, 2024
GlobeNewswire
4:05 PM
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad R...
GlobeNewswire
4:05 PM
Volvo Trucks North America Continues ‘Toward Zero’ by Fueling All New Trucks with HVO at the New Riv...
GlobeNewswire
4:05 PM
Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ...
GlobeNewswire
4:05 PM
Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 Amer...
GlobeNewswire
4:02 PM
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...
GlobeNewswire
4:01 PM
Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
4:00 PM
ML Tech’s Digital Asset Market Neutral Opportunities Fund Reaches Milestone of Six Months of Live Tr...
GlobeNewswire
4:00 PM
CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASC...
GlobeNewswire
4:00 PM
Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of ob...
GlobeNewswire
4:00 PM
ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual...
GlobeNewswire
4:00 PM
Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B...
GlobeNewswire
4:00 PM
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting